We aim to offer world-class assessment and treatment for people with allergic diseases and asthma. Specific interests of this practice include:
As you know, there is a high demand for Allergy & Asthma services. We currently have a 3 to 4 month wait-list for routine appointments. However all referrals are triaged by urgency and we do keep slots for urgent patients. Also if the patient and the referring doctor is willing to see another doctor in the practice we can usually fit people in sooner. We encourage referring doctors to call us if they are worried and we are happy to discuss the issue and make an urgent appointment if necessary.
The hay fever season is nearly upon us and many people in Melbourne suffer severely from it. It is usually due to an allergy to Rye grass pollens and is particularly severe from November to December. At this time there is also a risk for thunderstorm asthma which is a particular risk for those who suffer from hay fever.
The first line treatment for hay fever is topical nasal steroids used on a daily basis. People should use them regularly from the commencement of hay fever season ( mid October ) till the end of December. Additional treatments for severe symptoms include oral non-sedating antihistamines and/ or topical eye medications such as antihistamine eyedrops or mast cell stabilisers.
Immunotherapy is very effective but cannot be commenced during the hay fever season. Patients considering injection immunotherapy need to be seen by April and sublingual immunotherapy by July for commencement.
Clinicians working in MAAIC are involved in clinical trials studying new medications and treatment and also basic research exploring the underlying mechanisms of disease . All trials are approved by an independent Ethics and Research Committee and informed consent and written enrolment procedures are mandated. If a patient appears suitable for a trial they will be invited by their treating doctor and their consent sought. Patients are always free to volunteer, or not volunteer for research studies without affecting their care in any way. If a patient does consent, their referring doctor will be notified.